VYNE Therapeutics
VYNE
VYNE
59 hedge funds and large institutions have $139M invested in VYNE Therapeutics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+3
Holders Change %
+5.36%
% of All Funds
1.28%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
10
Increased
24
Reduced
15
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
First Manhattan
New York
|
+$7.31M |
| 2 |
O
OrbiMed
New York
|
+$4.98M |
| 3 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$4.41M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.97M |
| 5 |
DM
Deerfield Management
New York
|
+$1.56M |
